Beyond First Line: Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis

Expert faculty discuss the pharmacist’s role in the treatment of myelofibrosis with an on-demand webcast of a live symposium, downloadable slides, and commentary.

Share

Program Content

Activities

Novel Therapy for MF
Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 23, 2023

Activities

Novel Therapy for MF
Beyond First Line: Applying Evidence to Implement New and Novel Therapy in the Management of Myelofibrosis
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 23, 2023

Expires: June 22, 2024

Activities

MF Treatment
Pharmacists Discuss Practical Considerations and Novel Treatment Options for Patients With Myelofibrosis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2023

Provided by

ProCE Banner

Provided by ProCE, LLC

Supporters

Supported by an educational grant from GSK.

GSK

Partners

Clinical Care Options, LLC 123

ProCE Banner

Hematology/Oncology Pharmacy Association (HOPA)

ProCE Banner

 In partnership with Clinical Care Options, LLC and the Hematology/Oncology Pharmacy Association (HOPA)

Additional Information

In coordination with HOPA's Annual Conference